CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 43 filers reported holding CONATUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $20,000 | -91.3% | 11,800 | -78.1% | 0.00% | – |
| Q2 2018 | $230,000 | +618.8% | 53,874 | +888.0% | 0.00% | – |
| Q1 2018 | $32,000 | +68.4% | 5,453 | +30.8% | 0.00% | – |
| Q4 2017 | $19,000 | -80.4% | 4,170 | -76.4% | 0.00% | – |
| Q3 2017 | $97,000 | – | 17,661 | +88205.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 20 | -99.5% | 0.00% | – |
| Q4 2016 | $23,000 | – | 4,428 | +31528.6% | 0.00% | – |
| Q3 2016 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | -100.0% | 14 | -99.6% | 0.00% | – |
| Q1 2015 | $22,000 | +100.0% | 3,122 | +161.7% | 0.00% | – |
| Q2 2014 | $11,000 | +450.0% | 1,193 | +403.4% | 0.00% | – |
| Q1 2014 | $2,000 | +100.0% | 237 | +79.5% | 0.00% | – |
| Q4 2013 | $1,000 | -66.7% | 132 | -61.1% | 0.00% | – |
| Q3 2013 | $3,000 | – | 339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,192,080 | $9,704,000 | 4.11% |
| Ghost Tree Capital, LLC | 219,977 | $1,790,000 | 1.06% |
| JBF Capital, Inc. | 148,178 | $1,205,000 | 0.18% |
| Polar Capital LLP | 900,604 | $7,326,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 80,000 | $651,000 | 0.15% |
| HAMILTON LANE ADVISORS LLC | 33,141 | $270,000 | 0.11% |
| Jasper Ridge Partners, L.P. | 63,996 | $521,000 | 0.03% |
| Weiss Multi-Strategy Advisers LLC | 95,000 | $773,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 550,000 | $4,474,000 | 0.01% |
| AXA S.A. | 292,625 | $2,381,000 | 0.01% |